How has been the historical performance of Kashyap TeleMed.?
Kashyap TeleMed's historical performance shows stable net sales and operating income at 0.19 Cr for the last two years, with reduced total expenditure indicating cost management. However, profitability remains a challenge, with negative earnings per share and fluctuating operating profits, resulting in no profit before or after tax in recent years.
Answer:The historical performance of Kashyap TeleMed shows a consistent trend in net sales, remaining stable at 0.19 Cr in both Mar'24 and Mar'25, with a slight decline from 0.20 Cr in Mar'23 and Mar'22. Total operating income mirrored this stability, holding at 0.19 Cr in the latest two years. However, total expenditure, excluding depreciation, decreased from 0.30 Cr in Mar'22 to 0.19 Cr in Mar'25, indicating a reduction in costs. Despite this, the operating profit (PBDIT) has fluctuated, showing a loss of 0.03 Cr in Mar'24 and breaking even in Mar'25, after a profit of 0.01 Cr in Mar'23. Profit before tax also reflected this trend, with a loss of 0.03 Cr in Mar'24 and no profit in the following year. Profit after tax remained at zero in Mar'25, following a loss of 0.03 Cr in Mar'24 and a break-even in Mar'23. The earnings per share (EPS) have been negative in recent years, with a value of 0.0 in Mar'25 and -0.01 in Mar'24. The operating profit margin and PAT margin also showed negative figures in the last two years, indicating challenges in profitability.Breakdown:
Kashyap TeleMed's financial performance over the years reveals a stable net sales figure of 0.19 Cr for the last two years, with a slight decline from previous years. Total operating income has remained consistent at 0.19 Cr, while total expenditure has decreased, suggesting improved cost management. Operating profit showed a slight recovery in Mar'25, moving from a loss in the previous year to break-even, but profit before tax and profit after tax remained at zero, indicating ongoing profitability challenges. The company's EPS has been negative recently, reflecting difficulties in generating shareholder value. Overall, while there are signs of cost control, the company continues to face challenges in achieving profitability.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
